- HATIP #1, 13th March 2003
- HATIP #2, 27th March 2003
- HATIP #3, 10th April 2003
- HATIP #4, 24 April 2003
- HATIP #5, 8 May 2003
- HATIP #6, 23 May 2003
- HATIP #7, 12 June 2003
- HATIP #8, 26 June 2003
- HATIP #9, 10th July 2003
- HATIP #10, 24 July 2003
- HATIP #11, 7 August 2003
- HATIP #12, 28 August 2003
- HATIP #13, 11 September 2003
- HATIP #14, 2 October 2003
- HATIP #15, 9 October 2003
- HATIP #16, 23 October 2003
- HATIP #17 , November 6 2003
- HATIP #18 24 November 2003
- HATIP #19, 4 December 2003
- HATIP #20, 19 December 2003
HATIP #19, 4 December 2003
Main article: Palliative care and symptom management: Palliation vs Diagnosis and Cure
This week HATIP continues a series of articles exploring aspects of palliative care for people with HIV and AIDS. In this, our third article on the subject, our focus is on symptom management in under-resourced settings, keeping in mind that the best way to alleviate suffering is often to treat the underlying cause of the condition and thus prolong life.
Theo Smart wrote this article with contributions of advisory panel members Chris W. Green (Indonesia), Dr. Vijay Anthony Prabhu (Chennai, India), Pauline Ngunjiri (St. Kitts), Dr. Douglas Wilson (Pietermaritzberg, South Africa), and Dr. Harry Hausler (Cape Town, South Africa). Most of the recommendations on symptom care tips are reprinted from the Handbook of HIV Medicine (HHM), by Wilson, D et al. (Oxford University Press, Southern Africa, 2001.
Frequent symptoms
Two large studies in outpatients with AIDS address the spectrum of symptoms experienced by this population in the developed world. Fantoni et al. investigated the prevalence and intensity of symptoms in 1128 HIV-infected patients reporting to outpatient clinics in central Italy. The most common symptoms were asthenia/weakness (65%), anorexia (34%), cough (32%), pain (29%), and fever (29%). Another survey by Vogl et al. used a questionnaire, the Memorial Symptom Assessment Short-Form (see Assessment Tools, last issue) to explore the prevalence and distress caused by 32 different symptoms in 504 ambulatory patients with AIDS.
Twelve symptoms had prevalence figures of greater that 60%. These included worrying (86%), fatigue (85%), sadness (82%), pain (76%), feeling irritable (75%), difficulty sleeping (73.8%), feeling nervous (68%), dry mouth (67%), difficulty concentrating (64.5%), shortness of breath (62.4%), feeling drowsy (61.9%), and cough (60.3%).
HATIP Advisory Panel Member, Dr. Dr. Vijay Prabhu comments: What is interesting is that, in practice, one comes across most of these symptoms in a single patient, sometimes all at one time, reflecting the multisystem nature of HIV/AIDS.
Treating the symptoms vs treating the cause
In resource-limited settings, the lack of available disease-specific therapies for some conditions increases the need for symptom control and supportive therapies to improve the quality of life for people with HIV/AIDS.
Internationally, numerous palliative care programmes have been developed and non-governmental organisations/community-based organisations have set up home based care (HBC) teams to provide support, nursing or household help and to even dispense inexpensive symptom relieving drugs such as morphine or anti-histamines to people living with HIV/AIDS (PLHAs).
But some activists and doctors believe that there is an undue emphasis on palliative care over treatment.
On a governmental level, palliative care programmes have just been a way to duck out of providing treatment. They set up a cheap palliative care program to appear compassionate but they are actually just writing off people with AIDS, said one treatment educator in Cape Town. Palliative care providers are trained to expect or even anticipate the death of their patient, she continued sometimes they dont even think to look for the cause of a symptom.
And often, the best way to reduce suffering from a symptom is to diagnose and treat its cause. Some medications that can treat or prevent infections in PLHAs are relatively inexpensive to provide and could be administered with minimal trouble or discomfort to the patient. And if the illness causing the symptom is not treated, the patients suffering is likely to grow worse despite palliative care and could eventually cause the patients death.
Many causes of HIV death are due to potentially treatable conditions, Dr. Douglas Wilson noted in the last issue of HATIP. But PLHAs and people providing palliative care may not know when a condition they have is treatable. Part of the danger for patients receiving home-based palliative care, is that they are often beyond the reach of doctors or primary health care facilities. If palliative care programmes trained caregivers to recognise the signs of life-threatening conditions, they could perhaps refer the patient to a healthcare professional or primary care facility in time for diagnosis and treatment. But such education is often neglected.
Citing an example, the nursing educator told HATIP about a PLHA who was receiving palliative care from a HBC team. The patient had difficulty swallowing, couldnt eat and subsequently died of starvation. But her inability to swallow was caused by oesophageal candidiasis that could have been easy treated by fluconazole supplied to the patient for free. These sort of horror stories happen all the time she said.
Because of its historical associations with end-of-life care, there is this negative association that people on palliative care are going to die, which just feeds into the sense of fatalism that is so pervasive here."
"This makes the patient and their family worry about the financial burden that they will become, and the humiliation the family is enduring, particularly when there is so much AIDS bias. At a relatively early point in HIV disease, a person may fall ill from a treatable condition, such as bacterial pneumonia or TB. They arent referred to medical care but instead the palliative caregiver keeps them quiet and sedated, and their infection goes untreated until they die. A lot of people are just swept under the carpet this way, often to their familys relief.
She believes that fairly simple measures could do much to improve the health and quality of life for PLHA in the developing world even before the roll-out of antiretroviral therapy. Training first tier and community health care workers to recognise emerging symptoms and signs of serious illnesses such as TB and other life-threatening conditions would encourage more timely referral to a clinic or physician for diagnosis and treatment. However, many parts of the developing world are hundreds of kilometres away from such a facility. Likewise, physicians are in short supply. Nurses are often the only medical professional within easy access of most PLHAs. Such nurses are often faced with the challenge of trying to diagnose the cause of a symptom without ready access to pathology labs.
But even with this handicap, a nurse with a thorough understanding of the symptoms and illnesses in people with HIV can manage some of the more important infections. Very simple algorithms using symptoms and other clinical criteria can be taught successfully and used to diagnose some of the more common or serious treatable illnesses by nurses and community health care workers (and possibly even traditional healers.
HATIP Advisory Panel member, Chris Green adds: Many traditional healers have effective symptomatic responses to these symptoms. And frequently they have diagnostic powers which match those of allopathic healthcare workers.
While these algorithms might be crude and inexact compared to the definitive diagnosis at better-equipped facilities, and some patients will fall through the cracks or be misdiagnosed, they should be able to diagnose a number of treatable infections. Finally, the nurse should be provided with certain essential drug therapies and instructed how to safely administer and monitor the treatments in patients.
The approach may not be perfect, but it could prevent most of these unnecessary deaths by either managing the illness, or at least stabilizing the patient long enough to be able to refer them to a primary care facility., he went on.
But there are some concerns about this approach, such as making sure that the patient doesnt get lost in the Herculean effort to save his or her life. This worries me a little bit said Mr. Green for number of reasons. We run the risk of using heroic attempts to extend life in ways that neither the patient nor the family are comfortable with. Also, the side effects or other effects of some of these treatments may be worse than the condition.
I think we need to be very clear over the objective of the care which we are providing and ensure that all concerned understand this, and agree and accept it. We must be cognisant of the fact that people with AIDS are probably going to die unless they get ART fairly soon.This can be extremely distressing for carers and family. Thus the objectives may be to: (1) prolong life long enough to allow access to ART; allow the patient to achieve some milestone (Christmas, childs birthday or wedding, etc.); or conversely (3) die in reasonable comfort and dignity at home, with the support of family.
Many problems are extremely difficult to diagnose particularly fever and diarrhoea; Mr. Green continued patients can feel that the health care worker doesnt know what he/she is doing and is trying anything to cure the problem, that they are swallowing more and more (and more expensive) pills, that they are being used as guinea pigs, and that nothing seems to work, and they lose faith in the care giver, and lose hope.
HATIP Advisory Panel member Dr. Vijay Prabhu has laboured for years to provide salvage care for PLHAs who have received incompetent or bungled treatment from other doctors and health care workers. Understandably he is apprehensive of putting diagnosis and care into the hands of junior medical personal, not to mention non-traditional caregivers, or of accepting a lower standard of care that may be provided in such settings.
Defining roles
I believe that every life is precious and if simple measures can extend or improve the quality of his/her life, then it definitely needs to be done, but if quality of care is sacrificed by allowing health workers to dole out paracetamol in boxes, then the very purpose of this exercise is defeated. Surely AIDS patients have a right to access trained and qualified doctors, who can give them some semblance of a quality of life, at their own choosing and not make do with poorly trained and unmotivated workers who pose as "care providers"?
The role of health workers, their limitations and duties needs to be clearly defined. Use of communication hot lines and urgent referral to higher and most importantly competent, dedicated and motivated professionals is extremely important to be able to make a difference!! This unfortunately is not happening, as quickly as it needs to happen. Professional rivalry, barriers between state and private health partners and the ubiquitous NGOs with their own agendas, all add to the confusion, which the suffering patient is blissfully unaware of. He continues to think that his health care "provider" is a kind of "mini-God", because he is getting free drugs of paracetamol and Septrin, not realising that with every passing moment, the lack of quality care is injurious to his health! I have seen patients who have literally taken dozens of Septrins for PCP pneumonia, because their health care provider has told him to, when in fact he was suffering from bacterial pneumonia and bronchiectasis. Mistreatment and misguidance are simply not acceptable.
Although Dr. Prabhu may worry about the quality of care that might be provided by junior level healthcare workers, hes more clearly worried about substandard care, such as offering only palliative care for easily treatable conditions.
Cost of medicines
Treatments can be extremely costly, notes Chris Green. If not provided for free, there is a risk that people will mortgage their childrens future to obtain a few more weeks of life.
Thats where activists like Pauline Ngunjiri, HATIP Panel member originally from Kenya come in. She worked to make sure essential drug lists included treatments for common opportunistic infections and coinfections in AIDS. In Kenya where I am a member of a coalition on access, we check all the procedures about drug distribution. We have professional and or confrontational meetings with the dispensers and expose what we cannot handle through the media.
Symptom management
Symptoms may be managed by palliation or by treating the cause. In the most resource-constrained settings, without doctors, clinics or access to laboratories, a number of serious conditions can still be treated once a diagnosis is made on the basis of symptoms and other clinical criteria.
Diagnosis and treatment are most likely be carried out by trained nurses and possibly other community caregivers, such as traditional healers, if they have received adequate training make a diagnosis.
In some settings, these algorithms are very basic. For example, during times of transmission in a malaria endemic region, any pregnant woman or child with a fever should be given malaria treatment, unless the fever is found to be caused by something else. This results in women and children receiving treatment they do not need, but the risk of serious morbidity or death for those with malaria is too great to take the risk.
Few other algorithms are so simple. But for most symptoms in such settings, it is often impossible to confirm a diagnosis, thus there is little to do but offer the patient palliative care, unless the patient can be referred to more advanced facilities.
Further resources
Each future edition of HATIP will contain a new section called Practice Notes which will focus on the management of a particular symptom in clinical practice, with guidance for home based care.
A draft of a practical guidance manual for staff in first-level health care facilities has been published by WHO. The Integrated Management of Adolescent and Adult Illness interim guidelines include a module on Palliative care: symptom management and end of life care.
News headlines
A selection of news stories which have appeared since November 24th 2003.
India to begin free HIV treatment programme, will treat 100,000 within a year
**The Indian government will provide free antiretroviral treatment through government hospitals starting from April 2004, Health Minister Sushma Swaraj announced today. The Indian government plans to provide treatment for 100,000 people in the first year, at a cost of 2 billion rupees (US$40 million).
Treatment with HAART reduces liver-related mortality in HIV/HCV coinfected patients
**Treatment with HAART is associated with a lower rate of mortality from liver-related causes in individuals coinfected with HIV and hepatitis C virus (HCV), according to a German study published in the November 22nd edition of The Lancet.
HIV testing in Africa: will VCT for all do more than ABC approach?
**Two contrasting viewpoints on voluntary testing and counselling for HIV in developing countries are put forward this week in The Lancet. Whilst Dr Kevin De Cock of the US Centers for Disease Control in Kenya argues that universal voluntary counselling and HIV testing (VCT) is the only way to get a grip on the epidemic in sub-Saharan Africa, Dr Jeffrey Stringer of the Centre for Infectious Disease Research in Zambia suggests that in the short term, VCT cannot be implemented on the scale needed to meet one of the most ambitious United Nations goals the reduction of mother to child HIV transmission by 20% by 2005 and by 50% by 2010. Instead, he argues, nevirapine treatment should be universally deployed for all women giving birth in high prevalence areas.
Gastrointestinal side-effects lead one in eight to change HAART regimen in first year of treatment
**Over 50% of patients taking anti-HIV treatments for the first time will change or stop taking their drugs in the first year of therapy, often due to side-effects, and in many instances without telling their doctor first, according to US research published in the November 21st edition of the Journal of Acquired Immune Deficiency Syndromes. Investigators also found that gastrointestinal side-effects such as nausea, vomiting, and diarrhoea were the side-effects most often associated with a need to change treatment, accounting for 12.5% of all treatment changes.
HAART can be safely delayed until CD4 cell count falls to 200, provided individuals are adherent
**HIV-positive individuals can safely delay initiating HAART until their CD4 cell count falls to 200 cells/mm3 - provided they are adherent to their therapy, according to a Canadian study published in the November 18th edition of the Annals of Internal Medicine. The Canadian investigators also found that provided a patient is adherent to their therapy, individuals who started anti-HIV treatments when their CD4 cell count was 200 cells/mm3 were just as likely to survive as those who initiated HAART with a CD4 cell count of 350 cells/mm3 or above.
UNAIDS: Injecting drug use fuelling exploding HIV epidemics
**Injecting drug use (IDU) remains a significant HIV transmission factor in many regions of the world, driving fast-growing epidemics in Eastern Europe & Central Asia, Asia & the Pacific, Latin America and North Africa. For example, the HIV epidemic among adults in Libya has been driven by IDU, with 90% of all known HIV infections to date occurring among IDUs. Additionally, close to 25% of new HIV infections in the US and Canada last year were due to IDU, and in Portugal this mode of transmission was responsible for almost half of all HIV infections in 2002.
UNAIDS: HIV prevalence surges to 1.5m in Eastern Europe and Central Asia
**The number of people estimated to be living with HIV rose by 230,000 in Eastern Europe and Central Asia in 2003, from 1.27 million in 2002 to 1.5 million by the end of 2003, according to figures released today by UNAIDS ahead of World AIDS Day on December 1st.
UNAIDS: HIV prevalence increases 10% in South America and Caribbean
**The UNAIDS report on the HIV epidemic in South America and the Caribbean describes a region which witnessed a 10% increase in total HIV prevalence in the past year, and where prejudice means that resources are often not directed to the communities most in need of HIV prevention.
UNAIDS: Gay men still the group most affected by HIV in many rich countries
**HIV continues to spread amongst gay men in richer countries, according to the UNAIDS annual update on the world AIDS epidemic published today. The report highlighted that in several European countries, as well as Australia gay men still accounted for the majority of new infections. Resurgent epidemics of sexually transmitted infections (STIs), particularly syphilis, suggesting to UNAIDS an increase in risky sexual behaviour amongst gay men.
UNAIDS says one in five adults now HIV-positive in southern Africa
**Globally, five million people became infected with HIV in 2003, the worst year so far in the burgeoning epidemic. Of these, 700,000 are children under the age of 15. The majority of these infections occurred in sub-Saharan Africa.
Growing political momentum behind war on AIDS
**Britain will put AIDS at the centre of of its presidency of the G8 group of rich nations and the European Union in 2005, said Hilary Benn, UK Secretary of State for International Development, with a call for action due to be launched on December 1st that will urge more political commitment, more investment in prevention and treatment, better coordination of donors and better delivery of services on the ground.
WHO Announces 3 X 5 Plans
WHO unveils plans to treat 3 million by 2005
The World Health Organisation has published details of its plan to bring antiretroviral treatment to 3 million people living with HIV by the end of 2005.
International experts have agreed that a triple combination of d4T (stavudine), 3TC (lamivudine) and nevirapine is likely to be the best option for swift implementation of antiretroviral treatment in resource-limited settings. The recommendation was agreed at a WHO and UNAIDS-sponsored consultation in Zambia in mid-November, and follows a similar recommendation from a consensus meeting sponsored by Medecins sans Frontieres in September.
Community mobilisation key to success of 3 x 5
The WHO 3 x 5 plan envisages that community-based organisations, including groups of people living with HIV, will play a key role in scaling up treatment. This is not just a measure to plug gaps in the health services of heavily affected countries, but a response to evidence from early pilot programmes. These programmes have demonstrated that community participation is a key element in ensuring the acceptability of treatment. Making treatment part of the social fabric rather than a hidden enterprise is the only way to ensure long-term adherence.
About HATIP
A regular electronic newsletter for health care workers and community-based organisations on HIV treatment in resource-limited settings.
Its publication is supported by the UK government's Department for International Development (DfID), the Diana, Princess of Wales Memorial Fund and the Stop TB Department of the World Health Organization.
Other supporters include Positive Action GlaxoSmithKline (founding sponsor); Abbott Fund; Abbott Molecular; Cavidi; Elton John AIDS Foundation; Merck & Co., Inc.; Pfizer Ltd; F Hoffmann La Roche; Schering Plough; and Tibotec, a division of Janssen Cilag.
latest aidsmap news
- Urine biomarkers may predict cardiovascular disease in people taking antiretroviral therapy
- New TB/HIV guidelines released to improve care and treatment of drug users
- Two novel immune therapies in early investigation: autologous dendritic cells and CD4 zeta gene-modified T cells
- Treatment as prevention tool: enough evidence to say it works, says IAS president
- Tenofovir kidney toxicity most likely with high blood pressure medications and PIs
- Skills-building behavioral interventions advocated for reducing alcohol-related HIV risk in South Africa
- Criminal HIV transmission and exposure laws spreading around the world ‘like a virus’
- Prevention – there will be no magic bullet, we need ‘combination prevention’
- AIDS in 2031: where will we be?
- Major prevention success for sex workers and men who have sex with men in India
